IHE

iShares U.S. Pharmaceuticals ETF
A

60
*Unless otherwise stated, data provided by FactSet.

IHE Fund Description

IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.

IHE Factset Analytics Insight

IHE provides comprehensive but skewed coverage of pharmaceuticals, holding about 40 of the largest US pharmaceutical names, and capping large holdings in an industry where three players (J&J, Pfizer and Merck) take up more than 40% of the market cap. This heavily tilts IHE toward mid- and small-caps compared to our benchmark. While pharmaceuticals account for a hefty majority of IHE, the fund also holds positions in biotech. Its departures from neutral exposure seem to have resulted in a fund with greater volatility than the market it's trying to capture. IHE sees inconsistent trading volume, and retail investors should be wary of considerable spreads, though underlying liquidity is better for large investors. IHE charges a typical fee for its segment, and tracking is roughly in-line with that fee, if not a little better thanks to its securities lending program.

IHE MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of December 13, 2018 the iShares U.S. Pharmaceuticals ETF MSCI ESG Fund Quality Score is 4.84 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. IHE ranks in the 56th percentile within its peer group and in the 26th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

IHE CHARTS AND PERFORMANCE

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 12/13/18] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IHE -0.34% -8.38% 0.27% -0.75% 0.30% 7.55% 15.38%
IHE (NAV) -0.37% -8.50% 0.31% -0.84% 0.29% 7.53% 15.37%
DJ US Select / Pharmaceutical -0.35% -8.46% 0.45% -0.68% 0.54% 7.79% 15.37%
Thomson Reuters US Pharmaceuticals 1.47% 0.40% 11.59% 10.03% 8.50% 11.08% 14.77%
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IHE Top 10 Countries

IHE Top 10 Sectors

IHE Top 10 Holdings [View All]

IHE Summary Data

BlackRock
iShares
05/01/06
Open-Ended Fund
0.43%
$408.84M
$3.06M
0.11%

IHE Portfolio Data

$104.58B
-90.23
3.39
1.17%
12/17/18
45

IHE Index Data

DJ US Select / Pharmaceutical
Market Cap
Market Cap
Thomson Reuters US Pharmaceuticals

IHE Portfolio Management

0.43%
-0.18%
-0.13%
-0.27%

IHE Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IHE Fund Structure

Open-Ended Fund
No
Yes
72% / 29%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

IHE Factset Analytics Block Liquidity

As of 12/14/18
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IHE. IHE is rated a 5 out of 5.

IHE Tradability

19,664
$3.06M
11,478
$1.78M
0.11%
$0.17
-0.02%
0.65% / -0.53%
None
100.00%
50,000
0.23
0.00%
0.36%
436
$153.27
5

IHE Sector/Industry Breakdown


IHE
Segment Benchmark
79.70%
89.62%
11.50%
10.14%
4.32%
--
1.41%
--
1.34%
--
1.09%
--
0.65%
0.04%

IHE TOP 10 HOLDINGS[View All]

Mylan N.V. 2.84%
61.45%

IHE Countries


IHE
Segment Benchmark
100.00%
100.00%

IHE Regions


IHE
Segment Benchmark
100.00%
100.00%

IHE Economic Development


IHE
Segment Benchmark
100.00%
100.00%

IHE Performance Statistics

0.77
0.92
0.95
0.98
0.55%
Thomson Reuters US Pharmaceuticals

IHE MSCI ESG Ratings

4.84 / 10
55.72
26.31
--
2.61%
36.10

IHE BENCHMARK COMPARISON HOLDINGS

45
47
25
52.06%

IHE BENCHMARK COMPARISON SUMMARY


IHE
Segment Benchmark
45
47
$104.58B
$197.85B
-90.23
33.76
3.39
4.66
1.27%
2.33%
High
High

IHE BENCHMARK COMPARISON MARKET CAP SIZE


IHE
Segment Benchmark
55.43%
96.27%
12.24%
2.27%
30.37%
1.31%
1.95%
0.14%